JASON CLEMONS: Open Payments
NPI 1881031367 · BESSEMER, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$77 in 4 payments from 3 companies in 2025. Trend: 2023 $44 · 2024 $52 · 2025 $77
Food & beverage: $77
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: REXULTI, XIFAXAN.
Industry payments across AL — which companies pay providers there.
